Egyptian e-health startup Reme-D has raised US$1.45 million in pre-Series A funding to expand its manufacturing capacity, regional footprint, and diagnostic product portfolio. Founded in 2023 by Salma Tammam, Reme-D develops and manufactures molecular diagnostic tests for diseases including tuberculosis (TB), HIV, hepatitis, and HPV, with a focus on delivering affordable, temperature-resilient diagnostics for underserved [...]
The post Egyptian e-health startup Reme-D raises $1.45m pre-Series A funding appeared first on Disrupt Africa.